In our OX-40 knockout CTCL cell lines, the reduction in ERK signaling suggests that OX-40 is a critical upstream regulator of the ERK pathway, which drives tumor growth and dissemination in CTCL. This evidence concerns the gene TNFRSF4 and primary cutaneous T-cell non-Hodgkin lymphoma.